CLARITY about the use of Clopidogrel in patients with acute coronary syndromes and myocardial infarction

Expert Opinion on Pharmacotherapy

Volumn 6, Issue 10, 2005, Pages 1761-1764

  Doggrell, Sheila A ^a  

^a AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

Author keywords

Aspirin; CLARITY; Clinical trial; Clopidogrel; Cost effective; CURE

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; FIBRINOLYTIC AGENT; HEPARIN; PLACEBO;

ACUTE DISEASE; ANGIOCARDIOGRAPHY; ARTERY OCCLUSION; ARTICLE; BLEEDING DISORDER; CAUSE OF DEATH; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG USE; FIBRINOLYTIC THERAPY; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; RECURRENT DISEASE; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; CORONARY DISEASE; HUMANS; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; SYNDROME; TICLOPIDINE;

EID: 23844465642     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.6.10.1761     Document Type: Article

References (8)

1. WEINTRAUB WS, MAHONEY EM, LAMY A et al.: Long-term cost effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. J. Am. Coll. Cardiol. (2005) 45:838-845.
2. SABATINE MS, CANNON CP, GIBSON CM et al.: Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N. Engl. J. Med. (2005) 352:1179-1189.
3. CAPRIE STEERING COMMITTEE: Randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet (1996) 348:1329-1339.
4. YUSUSF S, ZHAO F, MEHTA SR et al.: The clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med. (2001) 345:494-502.
5. FOX KA, MEHTRA SR, PETERS R et al.: Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation (2004) 110:1202-1208.
6. BUDAJ A, YUSUF S, MEHTA SR et al.: Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation (2002) 106:1622-1626.
7. PETERS RJ, MEHTA SR, FOX KA et al.: Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes. Circulation (2003) 108:1682-1687.
8. LAMY A, JONSSON B, WEINTRAUB WS et al.: The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study. Eur. J. Cardiovasc. Prev. Rehabil. (2004) 11:460-465.